Diaz Alperi; Joaquin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Diaz Alperi; Joaquin.The latest application filed is for "method for improving the efficacy of curcuminoids and their analogs".

Company Profile

0.9.4

Diaz Alperi; Joaquin - Alicante ES
Diaz Alperi; Joaquin - Ali ES

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for improving the efficacy of curcuminoids and their analogs Grant 9,211,270 - Diaz Alperi , et al. December 15, 2	2015-12-15
Method for Improving the Efficacy of Curcuminoids and Their Analogs App 20140257170 - DIAZ ALPERI; Joaquin ; et al.	2014-09-11
Method for improving the therapeutic efficacy of curcuminoids and their analogs Grant 8,748,494 - Diaz Alperi , et al. June 10, 2	2014-06-10
Pharmacological activities of curcuma longa extracts Grant 6,841,177 - Quintanilla Almagro , et al. January 11, 2	2005-01-11
Pharmacological activities of Curcuma longa extracts App 20040126442 - Quintanilla Almagro, Eliseo ; et al.	2004-07-01
Pharmaceutical composition capable of regulating the expression of adhesion molecules Grant 6,706,293 - Quintanilla Almagro , et al. March 16, 2	2004-03-16
Hypericum perforatum l. oleoresin, procedure for obtaining it and uses of it Grant 6,699,512 - Quintanilla Almagro , et al. March 2, 2	2004-03-02
Method for preparing an olea europaea extract and method of use of the same Grant 6,676,980 - Quintanilla Almagro , et al. January 13, 2	2004-01-13
A Method For Preparing An Olea Europaea Extract And Method Of Use Of The Same App 20030017217 - Quintanilla Almagro, Eliseo ; et al.	2003-01-23
Hypericum Perforatum L. Oleoresin, Procedure for Obtaining it and Uses of it App 20020197337 - Quintanilla Almagro, Eliseo ; et al.	2002-12-26
Method for obtaining apolar and polar extracts of curcuma and applications thereof Grant 6,440,468 - Quintanilla Almagro , et al. August 27, 2	2002-08-27
Pharmaceutical composition of activity in the treatment of cognitive and/or neuroimmune dysfunctions Grant 5,601,829 - Quintanilla Almagro , et al. February 11, 1	1997-02-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.